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Background: Use of complementary and alternative medicine (CAM), particularly herbal and alternative medicine
supplements, for preconception care and fertility management is becoming increasingly common.
Aims: To determine the factors associated with the use of CAMs by women for preconception care.
Materials and Methods: 412 women who had visited an antenatal ‘ﬁrst visit’ clinic situated at a Brisbane obstetric
hospital or had visited a private ultrasound clinic in the same city for the purposes of a routinely indicated ultrasound scan
in the ﬁrst trimester were recruited into the study. Data were collected via a cross-sectional questionnaire.
Results: Complementary and alternative medicines (not including multivitamins) were used during preconception by
8.3% of women attending for obstetric care. Approximately half (55.8%) of women taking herbal and alternative medicines
ceased these medications on discovery of their pregnancy, though fewer (17.4%) ceased taking multivitamin supplements.
Baseline characteristics (age, education and income) are not signiﬁcantly different between CAM users and those who did
not take CAMs preconception. The results of statistical analyses showed that only visiting a practitioner to check for
health (OR = 2.00; 95% CI: 1.33, 3.00) and trying to lose weight prior to pregnancy (OR = 1.53; 95% CI: 1.00, 2.36)
were the key predictors for women using CAM during preconception.
Conclusions: Women do consume CAMs to enhance preconception care to a certain extent, though CAM users remain
in the minority. CAM users also tend to cease use once pregnant.
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Introduction
Complementary and alternative medicines (CAM) have
become increasingly utilised by patients in Australia, and
internationally, over the past few decades.1,2 One area in
which CAM is commonly used is in the area of women’s
health, particularly preconception care and fertility
management, with studies indicating prevalence of CAM
use ranging from 29 to 91%.3,4 The most frequent types
of CAM used in preconception care and fertility
management were herbal medicines, followed by
acupuncture and dietary guidance with the use of
supplements. Characteristics of the users of CAM for
preconception care and fertility management are similar to
those reported in the literature for general CAM use,
namely women who are older, with higher levels of
education, working as professionals and earning high
incomes.1,5 Emerging evidence suggests that high
utilisation extends beyond preconception care and fertility
to become a core part of many women’s pregnancy
management.6,7
Optimisation of the chance to achieve a successful
pregnancy is the primary reason women used CAM for
preconception care and fertility management.3 Positive
relationships with CAM providers and the empowerment
afforded through self-care are also strong reasons for
CAM use in preconception care and fertility
management.3 Previous exploration of Australian women
attending obstetric antenatal clinics in Adelaide found the
majority of women (62%) using CAM interventions for
preconception.8 However, high CAM use may not
automatically extend into pregnancy, with 41% of women
taking CAM ceasing these interventions, with concerns on
the impact of the unborn child being the primary reason
for cessation. Another prospective survey of 100 patients
attending an Adelaide infertility clinic found that 66% of
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attendees were using CAM, most commonly herbal and
nutritional medicines.9
A high proportion (49.4%) of Australian women also
consult with a CAM practitioner for pregnancy-related
health issues,10 with nearly half (48.2%) of women visiting
a conventional infertility clinic concurrently seeing a CAM
practitioner for preconception care and fertility
management (mainly naturopaths and chiropractors).
CAM interventions are more likely to be midwife-led than
obstetrician-led, midwives are more likely to be supportive
of CAM use than obstetricians, and midwives are more
likely to communicate with CAM practitioners than
obstetricians,11,12 suggesting that the maternity care
practitioner type may also inﬂuence CAM use for
preconception, fertility and pregnancy. It is therefore
important not only to explore CAM use amongst women
more generally, but also explore differences in CAM use
amongst differing birth settings.
The aim of this study was to help address the gap in the
knowledge of CAM use by women during preconception
by examining the prevalence of CAM use by women
attending an obstetric antenatal clinic or a private
ultrasound clinic; identifying the CAMs used by these
women; and to determine the demographical, health status
and pregnancy outcome factors signiﬁcantly associated
with use of CAM by these women.
Materials and Methods
Over a 6-week period (February–March 2006), successive
unselected women in early pregnancy stages whom had
visited a antenatal ‘ﬁrst visit’ clinic situated at a Brisbane
obstetric hospital (the Royal Brisbane and Women’s
Hospital) or had visited a private obstetrician in Brisbane
for the purpose of a routinely indicated ultrasound scan in
the ﬁrst trimester were asked to participate in the study.
Of the 512 women approached for the study, 412 agreed
to participate (80% consent rate), with 255 participants
being recruited from the public antenatal clinic (62%) and
157 recruited from a private ultrasound clinic (38%).13
The data collection instrument utilised in this study was
a questionnaire. The questionnaire contained 192 items
covering the following areas: the circumstances under
which the women became pregnant; activities undertaken
prior to becoming pregnant; medications used when the
women became pregnant, including complementary
medicine and other forms of medication; previous
pregnancies; exercise habits; diet; weight; health status;
alcohol and tobacco consumption and demographics. For
this study, women were classiﬁed as CAM users if they
responded ‘yes’ to the question: When you became pregnant
were you taking any herbal or alternative medicines? Folic
acid use and multivitamin use were asked in separate
questions and were not deﬁned as CAM for use in this
study.
Health status, pregnancy outcomes and demographic
measures of CAM users and nonusers were compared
using Pearson’s chi-square test. A parsimonious model
involving signiﬁcant variables was determined via a
stepwise backward removal process which was determined
using the likelihood ratio test. Statistical signiﬁcance was
set at the a = 0.05 level.
The study was approved by the Royal Brisbane and
Women’s Hospital Human Research Ethics Committee
(2006000105). Approval did not allow collection of
information regarding women who did not consent to
participate in the study.
Results
There were 412 women who completed the questionnaire,
of which 8.3% indicated that they used CAM for
preconception care. The herbal medicines reported by the
women were milk thistle (n = 8), dandelion (n = 8),
Chinese herbs (n = 7), ginseng (n = 2), ganoderma (a
medicinal mushroom extract) (n = 1), guarana (n = 1), St
John’s wort (n = 1), spirulina (n = 1), echinacea (n = 1)
and individualised herbs prescribed by a naturopathic
clinic (n = 1). The nutritional alternative medicines
reported by the women were omega 3 oils (ﬂax seed and
ﬁsh oils) (n = 7), iron (n = 3), vitamin B (n = 1), vitamin
C (n = 1), l-carnitine (n = 1), a ‘mineral matrix’
supplement (containing calcium, chromium, copper,
magnesium, manganese, potassium, selenium, sodium and
zinc) (n = 1), a glucosamine and chondroitin supplement
(n = 1), evening primrose oil (n = 1) and colloidal
minerals (n = 1). Three (n = 3) women reported using
homoeopathic medicines and one (n = 1) woman
reporting using an alternative medicine ‘digestive aid’
which was not classiﬁed. Multivitamin use and folic acid
use were also asked separately, with 41.7% (n = 172)
women reporting taking a multivitamin supplement and
56.3% (n = 232) of women reporting taking a folic acid
supplement. When CAM use was extended to include
multivitamin use, the prevalence of CAM use amongst
women in this study was 43.7% (n = 180). Of those taking
multivitamin supplements, 17.4% (n = 30) ceased these
supplements after discovery of their pregnancy, and 55.8%
of women taking other CAMs (n = 19) ceased these
medicines after discovering they were pregnant.
The associations between women who used CAM and
those who did not use herbal medicines by demographic
measures are presented in Table 1. No signiﬁcant
associations were identiﬁed in comparing CAM medicine
users and nonusers groups across education (P = 0.203),
employment status (P = 0.613), salary (P = 0.814) or
marital status (P = 0.116).
Table 1 also shows a comparison between CAM and
non-CAM users reporting alcohol and tobacco
consumption prior to pregnancy. Use of CAM medicines
was signiﬁcantly associated with smoking status
(P = 0.030). Speciﬁcally, 2.9% of women who used
CAMs were current smokers compared to 17.2% of
nonusers. There were no signiﬁcant associations between
women who did or did not use CAM and alcohol
consumption (P = 0.858).
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Table 2 shows the association between women who did
or did not use CAMs and various current pregnancy
characteristics. Women who had problems becoming
pregnant were signiﬁcantly more likely to use CAM than
women who did not have this problem (P = 0.041).
Speciﬁcally, 26.5% of women who used CAMs had
problems becoming pregnant compared to 13.6% of
women who did not use CAM. Additionally, women who
visited a doctor to check their health were less likely to use
CAM than those women who did not visit a doctor to
check their health (P = 0.013). Speciﬁcally, 26.5% of
women who used CAM visited a doctor compared to
48.5% of women who did not use CAM. Women
requiring fertility treatment to conceive were also found to
be more likely to use CAM (P = 0.041). Speciﬁcally,
17.6% of women who used CAM required fertility
treatment compared to 7.5% of women who did not use
herbal medicines. Women who changed their exercise
habits in preparation for pregnancy were more likely to
use CAM than women who did not change their exercise
habits (P = 0.031). Speciﬁcally, 26.5% of women who
used CAM had changed their exercise habits compared to
13.0% of women who did not use CAMs. Women who
consumed multivitamins were also more likely to be using
other CAMs (P = <0.001). There were no signiﬁcant
associations between CAM and non-CAM users for
women planning to become pregnant (P = 0.555),
consuming folic acid (P = 0.165) and those who stopped
taking herbal or alternative medicine (P = 0.946).
There were no signiﬁcant associations between women
who did or did not use CAM for any previous negative
pregnancy outcomes such as pre-eclampsia, miscarriage,
hypertension, previous birth defects, previously giving
birth to a baby who had spent more than 24 h in intensive
care or who was underweight or preterm (data not
shown). There were no signiﬁcant differences between
women who had previous successful pregnancies or
pregnancies that had been voluntarily terminated and their
CAM use (data not shown).
There were no differences between women’s perceived
health status (excellent, fair or poor) and no signiﬁcant
difference in health conditions and women’s CAM use.
There were no signiﬁcant differences between women’s
weight (overweight, normal weight, and underweight) and
women’s CAM use. Women who tried to lose weight were
signiﬁcantly more likely to use CAM than women who did
not try to lose weight (P < 0.001). Speciﬁcally, 61.8% of
women who used CAM tried to lose weight compared to
30.9% of women who did not use CAM. There were no
Table 1 Complementary and alternative medicine use by
demographic and substance abuse characteristics* = statistically












School 100 100 0.203
Trade/other qualiﬁcation 78.8 68.1
Other 21.2 31.9
Employment
Employed 69.7 65.3 0.613
Unemployed 30.3 34.7
Salary (AUD)
0–19 999 27.3 22.3 0.814
20 000–39 999 27.3 23.9
40 000–59 999 18.2 26.0
60 000–99 000 15.2 12.6
>100 000 12.1 15.3
Marital status
Married/de facto 78.8 65.3 0.116
Other 21.1 34.7
Alcohol and tobacco use
Tobacco consumption*
Current non-smoker 97.1 82.8 0.030
Smoker 2.9 17.2
Alcohol consumption
Non-drinker 52.9 50.4 0.858
Ex-drinker 11.8 9.9
Drinker 35.3 39.7
Table 2 Current and previous pregnancy characteristics by
CAM use* = statistically signiﬁcant result (p < 0.05)
Characteristics
Used CAM
PYes (n = 34) (%) No (n = 377) (%)
Current pregnancy characteristics
Did you plan to become pregnant?
Yes 70.6 65.6 0.555
No 34.4 29.4
Did you have any problems becoming pregnant?*
Yes 26.5 13.6 0.041
No 86.4 73.5
Did you visit a doctor to check your health?*
Yes 26.5 48.5 0.013
No 73.5 51.5
Did you take folic acid?
Yes 66.7 55.3 0.165
No 32.4 44.7
Did you take multivitamin supplements*
Yes 79.4 38.4 <0.001
No 20.6 61.6
Did you require fertility treatment to become pregnant?*
Yes 17.6 7.5 0.041
No 82.4 92.5
Did you stop taking herbal or alternative medicine?
Yes 48.5 50.0 0.946
No 51.5 50.0
Did you change any exercise habits in preparation for pregnancy?*
Yes 26.5 13.0 0.031
No 73.5 87.0
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signiﬁcant associations between women who did or did not
use CAM and any of the remaining health status measures.
Table 3 presents the results obtained from multiple
logistic regression modelling to determine the most
important predictive factors for CAM use during
preconception. Of all the variables within the current and
previous pregnancy outcomes, health status of women,
alcohol and tobacco consumption and demographic
measures, only visiting a practitioner to check for health
and trying to lose weight prior to pregnancy were the key
predictors for women using CAM as part of their
preconception care. That is, the odds of a women using
CAM is 2.00 (95% CI: 1.33, 3.00) times greater for those
trying to lose weight prior to pregnancy compared to
women who were not trying to lose weight. Women who
visited a doctor to check health prior to pregnancy were
1.53 (95% CI: 1.00, 2.36) times more likely to use CAM
compared to women who did not visit a doctor to check
their health prior to pregnancy.
Discussion
In this study, when vitamin supplements were excluded,
only a minority of women attending outpatient obstetric
services used CAM. The pattern of CAM use by women
in this study for preconception care and fertility
management is reﬂective of previous studies that have
focused on the prevalence of CAM for preconception
care.8,9 However, this study found that education, salary,
employment and marital status were not signiﬁcantly
associated with the use of CAM. This ﬁnding is
contradictory to other studies reporting that women who
have a higher income, were married, or tertiary educated
were more likely to use of CAM therapies for
preconception care or fertility management,3,14,15 and
general Australian population data suggest similar
associations with CAM use.1,2 The differences between
the ﬁndings of this study and that reported in the
literature may be due to the sampling from both the public
and the private sectors within Brisbane, where there are
multiple streams of antenatal care, as there appear to be
differing levels of integration, information and support of
CAM between different birth pathway cohorts.11 It is also
possible that our study lacked statistical power due to the
small sample size.
Analyses identiﬁed that women trying to lose weight and
those who visited a doctor prior to pregnancy were more
likely to use CAM for preconception care. Possible
explanations for this are that women who use CAM are
more proactive about their health, or alternatively, that
women who were using CAM had more concerns about
their health and were accessing a broader range of
healthcare practitioners including their doctor. Women in
this study who attempted to change health behaviours
positively (such as via exercise) were also more likely to be
CAM users. Additionally, one marker for proactive
preconception care (folic acid utilisation) showed no
statistical difference between CAM users and CAM
nonusers, but CAM use was signiﬁcantly associated with
multivitamin use, which may be a proxy for proactive
preconception care, given that levels of folic acid in most
multivitamins are also considered sufﬁcient. The idea that
women who use CAM are more proactive in their health-
seeking behaviours is consistent with the literature showing
that CAM use is signiﬁcantly associated with positive
health behaviours (such as lower tobacco use) and
increased utilisation of broader healthcare services.16
Studies have identiﬁed that many women attempt to lose
weight before becoming pregnant, to improve pregnancy
outcomes but also to address conditions such as high
cholesterol, thyroid disorders, obesity, polycystic ovarian
syndrome (PCOS), diabetes and infertility.13,17,18
However, results from this study indicated no signiﬁcant
associations for such health conditions except for women
seeking fertility treatments to help them with
preconception care. CAMs associated with weight loss also
appear to be those with the strongest evidence base in
fertility management,19 and this may affect the use of
these therapies by patients, either self-prescribed or
directed by a practitioner. The ﬁnding that recently
consulting with a medical practitioner is associated with
CAM use is consistent with previous studies which
indicate that CAM product, and practitioner use is used
concurrently with, rather than instead of, conventional
care, and that higher use of conventional services is
associated with higher use of CAM.6,10
Of note is the fact that many women using CAM
ceased such use upon discovery of their pregnancy. Again,
this ﬁnding appears consistent with previous studies9 and
indicates that women take a critical risk-beneﬁt approach
to CAM use in preconception, fertility management and
pregnancy, and appreciate the potential risks of CAM in
pregnancy. This cessation could also be affected by
healthcare provider views, given that safety in pregnancy is
the primary concern of CAM use amongst maternity care
providers.11 Many of the CAMs used by women in this
study do not appear to correlate to those with an
established evidence base,19 nor do they appear to be
those that are routinely recommended by CAM
practitioner literature.20 It is important to note that herbal
medicines are being used by women for preconception
care without sufﬁcient scientiﬁc evidence and no safety
assessments on toxicity of herbal supplements. Further,
ovarian follicular development and sperm maturation
occur for several months prior to conception, and so the
safety and impact of these agents need to be assessed with
Table 3 Multiple logistic models for predictive factors associated
with use of CAM by women in pregnancy
Predictors Odds ratio 95% CI P
Tried to lose weight
prior to pregnancy
1.995 1.329, 2.996 <0.001
Visit a doctor to check
health prior to pregnancy
1.533 0.996, 2.357 0.013
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regard to the long-term health of the offspring. Therefore,
given the risks associated with any ingestible medicine use
in preconception or pregnancy, urgent attention is
required to uncover the decision-making processes of
women related to self-prescribed medications and CAMs
as they relate to preconception and pregnancy care.
The strength of this study is that it is one of the few
studies to provide insights into the use of CAM for
preconception care. There are some limitations that need
to be considered when interpreting our study ﬁndings.
The study sample was recruited from two major clinics in
Brisbane, so the ﬁndings may not be necessarily
generalisable to the wider population. The health status
information provided was self-reported by the women, so
some bias could have been introduced. The utilisation of
herbal medicine and health service utilisation is also
deﬁned by self-report, so that ﬁndings could be affected
by recall bias.
Conclusion
Complementary and alternative medicine use amongst
women attending antenatal clinics is signiﬁcant, and CAM
use appears to be a strong and consistent phenomenon in
those using contemporary obstetric care. However, when
vitamin supplements are excluded, CAMs are only used
by a minority of women, though still at levels that warrant
clinician consideration. As such, there is a clear need for
research to help women and healthcare practitioners better
understanding the risks and potential beneﬁts associated
with CAM use prior to and after conception. Further
research is also required to explore women’s decision-
making processes when deciding to use herbal medicines
and the communication that exists between the women
and healthcare practitioners in relation to their use of
herbal medicines.
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